Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass

The purpose of the work was to study the impact of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA) and its degrading enzyme, dimethylarginine dimethylaminohydrolase (DDAH1), on atherosclerosis in subtotally nephrectomized (SNX) ApoE-deficient mice. Male DDAH1...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobi, Johannes, Maas, Renke, Arend, Michaela, Cordasic, Nada, Hilgers, Karl F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013579/
https://www.ncbi.nlm.nih.gov/pubmed/24690995
http://dx.doi.org/10.3390/ijms15045522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013579/
https://www.ncbi.nlm.nih.gov/pubmed/24690995
http://dx.doi.org/10.3390/ijms15045522

Ejemplares similares